Evidence map›Paper›PMID 33385107›Full record

ArticleJNCI cancer spectrum2020

Physical Activity for Oncological Patients in COVID-19 Era: No Time to Relax.

Alice Avancini, Ilaria Trestini, Daniela Tregnago, Joachim Wiskemann, Massimo Lanza, Michele Milella, Sara Pilotto

Open access · goldAbstract read
In one paragraph

Article in JNCI cancer spectrum, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alice AvanciniDepartment of Medicine, Biomedical, Clinical and Experimental Sciences, University of Verona, Verona, Italy.ORCID 0000-0003-2439-4799
Ilaria TrestiniDepartment of Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Daniela TregnagoDepartment of Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Joachim WiskemannDivision of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and University Clinic Heidelberg, Heidelberg, Germany.ORCID 0000-0002-5971-5436
Massimo LanzaNeurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID 0000-0001-9091-6589
Michele MilellaDepartment of Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.ORCID 0000-0002-3826-5237
Sara PilottoDepartment of Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.ORCID 0000-0003-2229-4874
University of Verona · ITHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whereas the coronavirus disease 2019 (COVID-19) storm is relentlessly progressing worldwide, a great effort from scientific societies has been made to give recommendations for safely continuing oncological care, prioritizing the interventions according to patients' condition and type and stage of tumor. Nevertheless, to date no specific suggestions regarding physical activity and exercise in cancer patients during the COVID-19 era have been released, neglecting the potential deleterious effects of quarantine and sedentary behaviour (imposed as containment measures against COVID-19), particularly in these subjects. Moreover, literature is constantly consolidating the crucial impact of regular physical activity in cancer in reducing recurrence and mortality risk. In this commentary, we discuss possible adaptations of the recently published exercise guidelines to the current pandemic emergency, proposing various modalities to prevent or mitigate the physical inactivity risk in cancer patients.

Identifiers

PMID33385107
PMCPMC7499670
OpenAlexW3080589256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.